SEARCH
Reporter's Take | Anti-trust case spooks Indian generic drug companies
Moneycontrol
2019-05-14
Views
285
Description
Share / Embed
Download This Video
Report
Moneycontrol’s Stanford Masters gets in conversation with Viswanath Pilla to know more about Anti-trust case spooks Indian generic drug companies and more…
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://vclip.net//embed/x78af32" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
03:04
Reporter's Take | E-commerce companies’ plan for new FDI policy
04:15
Reporter's Take | Rising OAIs raises concern for Indian drug cos.
03:42
Reporter's Take | GSP withdrawal may hit US margins of Indian drug cos.
01:18
25 batches of drugs of 18 pharma companies found substandard since January 2018 by BPPI
01:12
Trade Setup for Tuesday: 5 stocks to keep an eye on June 18
01:19
Trade Setup for Thursday: 5 stocks to keep an eye on May 23
01:22
End of the road for BSNL, MTNL?
01:08
LIC new premium more than doubles in June; pushes industry collection to Rs 32,241 crore
00:59
Maruti Suzuki may completely move Brezza production to Toyota’s Bengaluru plant
00:49
PMC Bank crisis: Your money is safe, RBI assures depositors
08:25
Macro@Moneycontrol │ New rules to benefit passengers for delayed, cancelled flights
25:51
US government wants reciprocity in trade deals: Brian Moynihan, CEO, Bank of America